Clinical Trial Update: Duobrii Treatment of Acne Keloidalis Nuchae (AKN) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Duobrii for Acne Keloidalis Nuchae was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Keloidalis Nuchae

Drugs mentioned

• Duobrii (halobetasol propionate and tazarotene)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Acne Keloidalis Nuchae, AKN | Phase 3 | Status: TERMINATED | Results posted: 2025-10-31